Spontaneous short-term variations of circulating endothelin-1 in pulmonary hypertension

Translational Research

Volumn 151, Issue 3, 2008, Pages 119-121

  Charloux, Anne ^a   Chaouat, Ari ^b   Brandenberger, Gabrielle ^a   Piquard, François ^a   Weitzenblum, Emmanuel ^b   Geny, Bernard ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1;

CLINICAL ARTICLE; HUMAN; LETTER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; VARIANCE;

EID: 38949166359     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2007.11.003     Document Type: Letter

References (15)

1. Galie N., Manes A., and Branzi A. The endothelin system in pulmonary arterial hypertension. Cardiovasc Res 61 (2004) 227-237
2. Perros F., Dorfmuller P., and Humbert M. Current insights on the pathogenesis of pulmonary arterial hypertension. Semin Respir Crit Care Med 26 (2005) 355-364
3. Van Cauter E. Estimating false-positive and false-negative errors in analyses of hormonal pulsatility. Am J Physiol 254 (1988) E786-E794
4. Stewart D.J., Levy R.D., Cernacek P., and Langleben D. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?. Ann Intern Med 114 (1991) 464-469
5. Dupuis J., Cernacek P., Tardif J.C., et al. Reduced pulmonary clearance of endothelin-1 in pulmonary hypertension. Am Heart J 135 (1998) 614-620
6. Bauer M., Wilkens H., Langer F., Schneider S.O., Lausberg H., and Schafers H.J. Selective upregulation of endothelin B receptor gene expression in severe pulmonary hypertension. Circulation 105 (2002) 1034-1036
7. Jia B., Zhang S., Chen Z., et al. Plasma endothelin 1 concentrations in children with congenital heart defects. Minerva Pediatr 50 (1998) 99-103
8. Nootens M., Kaufmann E., Rector T., et al. Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels. J Am Coll Cardiol 26 (1995) 1581-1585
9. Cacoub P., Dorent R., Nataf P., et al. Endothelin-1 in the lungs of patients with pulmonary hypertension. Cardiovasc Res 33 (1997) 196-200
10. Van Beneden R., Gurne O., Selvais P.L., et al. Superiority of big endothelin-1 and endothelin-1 over natriuretic peptides in predicting survival in severe congestive heart failure: a 7-year follow-up study. J Card Fail 10 (2004) 490-495
11. Aronson D., and Burger A.J. Neurohormonal prediction of mortality following admission for decompensated heart failure. Am J Cardiol 91 (2003) 245-248
12. Fraser C.G. Test result variation and the quality of evidence-based clinical guidelines. Clin Chim Acta 346 (2004) 19-24
13. Franceschini R., Gandolfo C., Cataldi A., et al. Twenty-four-hour endothelin-1 secretory pattern in stroke patients. Biomed Pharmacother 55 (2001) 272-276
14. Herold M., Cornelissen G., Loeckinger A., Koeberle D., Koenig P., and Halberg F. About 8-hour variation of circulating human endothelin-1. Peptides 19 (1998) 821-825
15. Onuoha G.N., Nugent A.M., Hunter S.J., et al. Neuropeptide variability in man. Eur J Clin Invest 30 (2000) 570-577